2009
DOI: 10.1002/gepi.20410
|View full text |Cite
|
Sign up to set email alerts
|

STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement

Abstract: Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information in the practice of medicine and public health. Assessment of the strengths and weaknesses of this evidence, and hence the ability to synthesize it, has been limited by inadequate reporting of results. The STrengthening the REporting of Genetic Association studies (STREGA) initiative builds on the Strengthening the Reporting of Observational S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
182
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 290 publications
(182 citation statements)
references
References 144 publications
0
182
0
Order By: Relevance
“…6 In this context, the data on ANXA11 genetic variation and expression in sarcoidosis from other major ethnic groups are highly desirable. 21 …”
Section: Resultsmentioning
confidence: 99%
“…6 In this context, the data on ANXA11 genetic variation and expression in sarcoidosis from other major ethnic groups are highly desirable. 21 …”
Section: Resultsmentioning
confidence: 99%
“…Indeed, the concerns expressed by Charney and English echo previously published official guidelines in the genetics community. After noting that "making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics," the baseline recommendation of the relevant report (known as STREGA) is not that CGA studies be discontinued but rather that the quality of the research design and the "transparency of reporting" be enhanced (Little et al 2009). …”
Section: Discussionmentioning
confidence: 99%
“…Randomized controlled trials CONSORT extension to cluster randomized trials 12 Cluster randomized trials CONSORT extension to noninferiority/equivalence trials 13 Noninferiority/equivalence trials CONSORT for TCM 14 Trials of traditional Chinese medicine CONSORT extension to nonpharmacological treatment 15 Trials of nonpharmacological treatment STROBE 16 Observational studies STROBE-ME 17 Molecular epidemiology studies STREGA 18 Genetic association studies RECORD 19 Observational studies conducted using routinely collected health data REMARK 20 Tumor marker prognostic studies and information presented in an obscure or less than optimum format. 10 A large systematic review that was updated in 2012 assessed the effect of journal endorsement of the CONSORT checklist.…”
Section: Consort 11mentioning
confidence: 99%